Medistim
ISIN: NO0010159684 | Ticker: MEDI | LEI: 5967007LIEEXZXJOX483
Country: Norway
Cardiac and vascular diseases continue to be the most common cause of death in the western world. Globally, more than 700.000 patients undergo coronary artery bypass surgery annually while about 600.000 patients have vascular surgery procedures performed. Medistim’s mission over the past three decades has been to serve patients, surgeons and health care providers with innovative and cost effective medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the quality and outcome of cardiac and vascular surgery.
One million beating hearts later, we have set the standard in the field.
Today, Medistim’s proprietary products are regarded to be standard-of-care in most European countries and Japan, while market adoption is growing in the USA, Asia and the Middle East. In addition, Medistim in Norway represents about 100 different medical technology companies, as a distributor of their products in this country.
1984
Served areaWorldwide
HeadquartersPostboks 6471, 0605 Oslo – Norway
| Line item in (nok) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 345,820,000.00 | 403,244,000.00 | 482,659,000.00 |
| Noncurrent Assets | N/A | 100,033,000.00 | 96,747,000.00 | 96,764,000.00 |
| Property Plant And Equipment | N/A | 64,684,000.00 | 58,862,000.00 | 51,312,000.00 |
| Other Noncurrent Receivables | N/A | 1,886,000.00 | 4,475,000.00 | 5,793,000.00 |
| Deferred Tax Assets | N/A | 775,000.00 | 3,240,000.00 | 3,591,000.00 |
| Current Assets | N/A | 245,787,000.00 | 306,497,000.00 | 385,894,000.00 |
| Inventories | N/A | 112,667,000.00 | 97,413,000.00 | 114,333,000.00 |
| Current Trade Receivables | N/A | 57,485,000.00 | 68,634,000.00 | 101,657,000.00 |
| Other Current Receivables | N/A | 3,744,000.00 | 10,960,000.00 | 17,263,000.00 |
| Cash and cash equivalents | N/A | 65,761,000.00 | 124,866,000.00 | 144,164,000.00 |
| Cash | 66,745,000.00 | 71,891,000.00 | 129,490,000.00 | 152,641,000.00 |
| Equity And Liabilities | N/A | 345,820,000.00 | 403,244,000.00 | 482,659,000.00 |
| Equity | 236,861,000.00 | 256,845,000.00 | 306,052,000.00 | 367,691,000.00 |
| Issued Capital | N/A | 4,585,000.00 | 4,585,000.00 | 4,585,000.00 |
| Retained Earnings | N/A | 203,899,000.00 | 240,160,000.00 | 285,350,000.00 |
| Share Premium | N/A | 41,852,000.00 | 41,852,000.00 | 41,852,000.00 |
| Treasury Shares | N/A | 33,000.00 | 26,000.00 | 21,000.00 |
| Other Reserves | N/A | 781,000.00 | 6,138,000.00 | 17,184,000.00 |
| Additional Paidin Capital | N/A | 5,762,000.00 | 13,344,000.00 | 18,742,000.00 |
| Liabilities | N/A | 88,974,000.00 | 97,192,000.00 | 114,967,000.00 |
| Noncurrent Liabilities | N/A | 29,497,000.00 | 19,589,000.00 | 15,146,000.00 |
| Noncurrent Deferred Income Including Noncurrent Contract Liabilities | N/A | N/A | 2,510,000.00 | 5,126,000.00 |
| Longterm Borrowings | N/A | 7,580,000.00 | 0.00 | N/A |
| Current Liabilities | N/A | 59,477,000.00 | 77,604,000.00 | 99,822,000.00 |
| Current Provisions | N/A | 150,000.00 | 350,000.00 | 350,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 13,530,000.00 | 13,205,000.00 | 24,470,000.00 |
| Current Tax Liabilities Current | N/A | 12,307,000.00 | 20,327,000.00 | 25,873,000.00 |
| Other Current Liabilities | N/A | 23,610,000.00 | 36,609,000.00 | 42,043,000.00 |
| Line item in (nok) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 356,207,000.00 | 417,817,000.00 | 486,262,000.00 |
| Other Income | 6,926,000.00 | 9,459,000.00 | 5,675,000.00 |
| Changes In Inventories Of Finished Goods And Work In Progress | 76,577,000.00 | 97,114,000.00 | 106,485,000.00 |
| Employee Benefits Expense | 119,066,000.00 | 134,507,000.00 | 146,376,000.00 |
| Depreciation And Amortisation Expense | 23,141,000.00 | 23,427,000.00 | 23,288,000.00 |
| Other Expense By Nature | 48,865,000.00 | 55,950,000.00 | 74,537,000.00 |
| Profit Loss From Operating Activities | 95,484,000.00 | 116,278,000.00 | 141,251,000.00 |
| Finance Income | 14,137,000.00 | 8,173,000.00 | 16,546,000.00 |
| Finance Costs | 18,015,000.00 | 10,380,000.00 | 11,748,000.00 |
| Profit Loss Before Tax | 91,606,000.00 | 114,071,000.00 | 146,049,000.00 |
| Income Tax Expense Continuing Operations | 22,219,000.00 | 23,171,000.00 | 32,077,000.00 |
| Profit (loss) | 69,387,000.00 | 90,900,000.00 | 113,973,000.00 |
| Line item in (nok) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | 69,387,000.00 | 90,900,000.00 | 113,973,000.00 |
| Adjustments For Income Tax Expense | 22,219,000.00 | 23,171,000.00 | 32,077,000.00 |
| Adjustments For Decrease Increase In Inventories | -22,597,000.00 | 15,254,000.00 | -16,920,000.00 |
| Adjustments For Increase Decrease In Trade Account Payable | -1,298,000.00 | -324,000.00 | 11,265,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 23,427,000.00 | 23,288,000.00 |
| Cash Flows From Used In Operating Activities | 74,133,000.00 | 127,374,000.00 | 113,491,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 7,450,000.00 | 7,403,000.00 | 9,251,000.00 |
| Cash Flows From Used In Investing Activities | -10,639,000.00 | -11,486,000.00 | -21,102,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 3,000,000.00 | 4,500,000.00 | 0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 6,680,000.00 | 7,502,000.00 | 7,312,000.00 |
| Dividends Paid Classified As Financing Activities | 50,052,000.00 | 54,640,000.00 | 68,396,000.00 |
| Other Inflows Outflows Of Cash Classified As Financing Activities | 1,385,000.00 | 7,589,000.00 | 5,404,000.00 |
| Cash Flows From Used In Financing Activities | -58,347,000.00 | -59,053,000.00 | -70,304,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 764,000.00 | 1,066,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 5,147,000.00 | 57,599,000.00 | 23,151,000.00 |
| Cash and cash equivalents | 65,761,000.00 | 124,866,000.00 | 144,164,000.00 |
Please note that some sums might not add up.
NO0010159684
LEI5967007LIEEXZXJOX483
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.